RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure 
China's Energy Resilience Shields Economy From Global Oil Shock, Goldman Sachs Says 
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit 
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook 
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment 
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports 
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire 
Britain Courts Anthropic Amid US Defense Department Dispute 
Gold Prices Drop as Trump Escalates Iran Threats, Oil Surges 
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate 
Strait of Hormuz Crisis Fuels Oil Surge as Asian Markets Brace for Impact 
Dollar Holds Steady as Yen Nears Critical 160 Level Amid Iran War Escalation 
Iran's Stranglehold on the Strait of Hormuz: What It Means for Global Markets 
Strait of Hormuz Disruption Sparks Global Oil Supply Fears 
Vietnam GDP Growth Slows in Q1 2026 Amid Middle East Oil Crisis 
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage 
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover 
Altria Group Inc., an American tobacco company that is one of the largest producers of cigarettes and related products in the world, is buying NJOY e-cigarette and vaping startup for almost $2.8 billion.
Altria also holds the rights to the Marlboro cigarette brand in the United States, and on Monday this week, it announced its agreement to acquire NJOY. This comes after the company lost billions when it invested in another e-cigarette company, Juul.
As per Reuters, a number of major tobacco companies have recently been investing heavily in cigarette alternatives as the smoking rates around the world continue to fall. Although the e-cigarette and vaping are also facing tough regulatory scrutiny as many minors are getting into the habit of “smoking,” Altria is still pushing through with the cigarette alternative business.
It was reported that Altria is betting that NJOY will provide it with an easier way to push into the market since six of its products have already received full approval from the U.S. Food and Drug Administration (USFDA).
On the other hand, Juul is still in the middle of seeking the same approval for its e-cigarette line. It is having difficulties with the process after it was criticized for its threat to health and use by minors.
To fund the deal with NJOY, Altria will use cash from a $2.7 billion agreement it had with Philip Morris International last year for its IQOS heated tobacco line. It was said that the contract with NJOY would include an additional $500 million in cash payments as per the regulatory approvals of its other products.
“We believe we can responsibly accelerate U.S. adult smoker and competitive adult vaper adoption of NJOY ACE in ways that NJOY could not as a standalone company,” Altria’s chief executive officer, Billy Gifford, said in a press release. “We believe the strengths of our commercial resources can benefit adult tobacco consumers and expand competition. We are also excited to welcome NJOY's talented employees to Altria at closing.”
Photo by: Brendan Stephens/Unsplash
